Cutler Group’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-600
Closed -$10.8K 3764
2022
Q4
$10K Sell
600
-200
-25% -$3.49K ﹤0.01% 2676
2022
Q3
$11K Sell
800
-7,908
-91% -$133K ﹤0.01% 3045
2022
Q2
$137K Sell
8,708
-4,848
-36% -$95.1K 0.02% 1242
2022
Q1
$365K Buy
13,556
+11,938
+738% +$305K 0.03% 815
2021
Q4
$59K Buy
1,618
+731
+82% +$29.8K ﹤0.01% 2264
2021
Q3
$42K Sell
887
-2,013
-69% -$90.2K ﹤0.01% 2652
2021
Q2
$98K Buy
2,900
+2,366
+443% +$80.1K 0.01% 1898
2021
Q1
$22K Sell
534
-9,966
-95% -$594K ﹤0.01% 3123
2020
Q4
$455K Buy
10,500
+4,798
+84% +$325K 0.04% 677
2020
Q3
$244K Buy
5,702
+1,864
+49% +$92.5K 0.03% 833
2020
Q2
$179K Buy
3,838
+2,838
+284% +$97.8K 0.02% 934
2020
Q1
$13K Sell
1,000
-200
-17% -$2.56K ﹤0.01% 2556
2019
Q4
$13K Buy
1,200
+400
+50% +$4.19K ﹤0.01% 2469
2019
Q3
$8K Sell
800
-100
-11% -$1.08K ﹤0.01% 2722
2019
Q2
$8K Buy
+900
New +$6.61K ﹤0.01% 2807
2017
Q1
Sell
-2,007
Closed -$29K 6333
2016
Q4
$29K Sell
2,007
-1,440
-42% -$21.5K ﹤0.01% 3079
2016
Q3
$59K Sell
3,447
-266
-7% -$8.59K ﹤0.01% 2293
2016
Q2
$116K Buy
3,713
+486
+15% +$15.3K 0.01% 1556
2016
Q1
$85K Buy
3,227
+328
+11% +$11.1K 0.01% 1760
2015
Q4
$127K Buy
+2,899
New +$131K 0.01% 1555

Other funds holding ARCT